Autori: Sette CVDM
| Naslov | POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic nonesmall cell lung cancer (mNSCLC) (Meeting Abstract) |
| Autori | Lu S Vynnychenko O Kulyaba Y Kuchava V Ibrahim A Moiseenko FV Arslan C Nguyen DT Zhang M Petrovic MD Cicin I Bibichadze K Cil T Cornfeld M Tian C Munteanu M Sette CVDM Bondarenko I |
| Info | ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 4, str. S1633-S1634 |
| Projekat | Incyte Corporation, Wilmington, DE, USA |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
